Revenue Agenda
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Revenue Agenda
No Result
View All Result
Home Editor's Pick

CVS Health to pull decongestants with phenylephrine off shelves

by
October 20, 2023
in Editor's Pick
0
CVS Health to pull decongestants with phenylephrine off shelves
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

U.S. pharmacy chain CVS Health said on Thursday it is pulling some of the most common decongestants with phenylephrine as the only active ingredient from its shelves and will no longer sell them.

The move comes after a panel of advisers to U.S. health regulators raised doubts over the efficacy of the ingredient.

Last month, the panel refused to back the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, adding that no more trials were required to prove otherwise.

CVS said “other oral cough and cold products will continue to be offered to meet consumer needs.”

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Phenylephrine is a major component used in some of popular products like Benadryl, Sudafed, GSK’s Advil and Kenvue’s Tylenol.

This post appeared first on NBC NEWS
Previous Post

Hunter Biden prosecutor David Weiss to appear for closed-door House Judiciary interview next month

Next Post

Elon Musk’s X removes the New York Times’ verification badge

Next Post
Elon Musk’s X removes the New York Times’ verification badge

Elon Musk’s X removes the New York Times’ verification badge

  • Trending
  • Comments
  • Latest
Top 10 Potash Countries by Production (Updated 2024)

Top 10 Potash Countries by Production (Updated 2024)

August 21, 2024
Top 10 Phosphate Countries by Production (Updated 2024)

Top 10 Phosphate Countries by Production (Updated 2024)

August 1, 2024
Top 10 Cobalt Producers by Country (Updated 2024)

Top 10 Cobalt Producers by Country (Updated 2024)

September 19, 2024
Sen. Peter Welch says Israel ground invasion would ‘exacerbate’ conditions in Gaza: ‘Grave concerns’

Sen. Peter Welch says Israel ground invasion would ‘exacerbate’ conditions in Gaza: ‘Grave concerns’

October 24, 2023
Juggernaut Exploration

Juggernaut Exploration

0
New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

0

Pennsylvania House clears tax credits for new teachers, nurses, police officers

0
Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

0
Juggernaut Exploration

Juggernaut Exploration

June 14, 2025
Skyharbour Resources

Skyharbour Resources

June 14, 2025
LaFleur Minerals

LaFleur Minerals

June 14, 2025
Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

June 14, 2025
Enter Your Information Below To Receive Trading Ideas and Latest News

Error: Contact form not found.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent News

Juggernaut Exploration

Juggernaut Exploration

June 14, 2025
Skyharbour Resources

Skyharbour Resources

June 14, 2025
LaFleur Minerals

LaFleur Minerals

June 14, 2025
Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

June 14, 2025
  • About us
  • Privacy Policy
  • Terms & Conditions
  • About us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 revenueagenda.com | All Rights Reserved

No Result
View All Result
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy

Copyright © 2025 revenueagenda.com | All Rights Reserved